Evidence map›Paper›PMID 34961794›Full record

ArticleNature cell biology2022

Histone variant H3.3 maintains adult haematopoietic stem cell homeostasis by enforcing chromatin adaptability.

Peipei Guo, Ying Liu, Fuqiang Geng, Andrew W Daman, Xiaoyu Liu, Liangwen Zhong, Arjun Ravishankar, Raphael Lis, José Gabriel Barcia Durán, Tomer Itkin and 8 more

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Nature cell biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Epigenetic regulation of CD8Frontiers in immunology · 2025
    Review
  14. Review
  15. Article
  16. Histone methyltransferase SETDB1 safeguards mouse fetal hematopoiesis by suppressing activation of cryptic enhancers.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors at 1 institution in 2 countries.

Peipei Guo *Department of Medicine, Division of Regenerative Medicine, Ansary Stem Cell Institute, Weill Cornell Medicine, New York, NY, USA. peg2005@med.cornell.edu.ORCID http://orcid.org/0000-0002-0525-1066
Ying Liu *Department of Medicine, Division of Regenerative Medicine, Ansary Stem Cell Institute, Weill Cornell Medicine, New York, NY, USA.
Fuqiang GengDepartment of Medicine, Division of Regenerative Medicine, Ansary Stem Cell Institute, Weill Cornell Medicine, New York, NY, USA.
Andrew W DamanDepartment of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.
Xiaoyu LiuRonald O. Perelman and Claudia Cohen Center for Reproductive Medicine, Weill Cornell Medicine, New York, NY, USA.ORCID http://orcid.org/0000-0001-6622-9316
Liangwen ZhongRonald O. Perelman and Claudia Cohen Center for Reproductive Medicine, Weill Cornell Medicine, New York, NY, USA.ORCID http://orcid.org/0000-0002-5397-3880
Arjun RavishankarDepartment of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.ORCID http://orcid.org/0000-0001-8366-4838
Raphael LisDepartment of Medicine, Division of Regenerative Medicine, Ansary Stem Cell Institute, Weill Cornell Medicine, New York, NY, USA.ORCID http://orcid.org/0000-0003-2541-4798
José Gabriel Barcia DuránDepartment of Medicine, Division of Regenerative Medicine, Ansary Stem Cell Institute, Weill Cornell Medicine, New York, NY, USA.ORCID http://orcid.org/0000-0003-4764-5503
Tomer ItkinDepartment of Medicine, Division of Regenerative Medicine, Ansary Stem Cell Institute, Weill Cornell Medicine, New York, NY, USA.
Fanying TangSandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.
Tuo ZhangWeill Cornell Genomics Core Facility, New York, NY, USA.ORCID http://orcid.org/0000-0001-5396-918X
Jenny XiangWeill Cornell Genomics Core Facility, New York, NY, USA.
Koji ShidoDepartment of Medicine, Division of Regenerative Medicine, Ansary Stem Cell Institute, Weill Cornell Medicine, New York, NY, USA.ORCID http://orcid.org/0000-0001-6303-3238
Bi-Sen DingDepartment of Medicine, Division of Regenerative Medicine, Ansary Stem Cell Institute, Weill Cornell Medicine, New York, NY, USA.
Duancheng WenRonald O. Perelman and Claudia Cohen Center for Reproductive Medicine, Weill Cornell Medicine, New York, NY, USA. duw2001@med.cornell.edu.
Steven Z JosefowiczDepartment of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.
Shahin RafiiDepartment of Medicine, Division of Regenerative Medicine, Ansary Stem Cell Institute, Weill Cornell Medicine, New York, NY, USA. srafii@med.cornell.edu.ORCID http://orcid.org/0000-0001-5605-1067
Cornell University · US

Funding

Structure, Function, and Dynamics of Macro-molecular Complexes that Execute and Regulate Genome FunctionRM1GM139738 · NIGMS · CORNELL UNIVERSITY · PI Thomas George Wade Graham, Steven Zvi Josefowicz · 2021 to 2026
$14.4M
Adaptable tissue-specific endothelial cells for organ regenerationR35HL150809 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI Shahin Rafii · 2020 to 2026
$7.1M
Histone Variant H3.3 as a Transcription Rheostat in the Immune SystemR01AI148416 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI Steven Zvi Josefowicz · 2020 to 2026
$4.6M
Endothelial cell transplantation for multi-organ repair to counter radiation injuryU01AI138329 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI KIEM, HANS-PETER, RAFII, SHAHIN · 2018 to 2022
$3.3M
Niche signals in HSC genesisRC2DK114777 · NIDDK · FRED HUTCHINSON CANCER RESEARCH CENTER · PI BERNSTEIN, IRWIN D, RAFII, SHAHIN · 2017 to 2021
$3.3M
Endothelial cell-derived MMP14 in lung alveolar regeneration and fibrosisR01HL130826 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI POWELL, CHARLES A. · 2016 to 2020
$2.4M
H3.3-mediated epigenetic regulation of developmental bivalent genes for reprogramming and differentiationR01GM129380 · NIGMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI WEN, DUANCHENG · 2018 to 2022
$1.8M
Direct generation of complex genetically-modified mouse models via embryonic stem cellsR21OD031973 · OD · WEILL MEDICAL COLL OF CORNELL UNIV · PI WEN, DUANCHENG · 2022 to 2023
$466k
NHLBI NIH HHS R01 HL130826NHLBI NIH HHS R35 HL150809NIAID NIH HHS R01 AI148416NIAID NIH HHS U01 AI138329NIDDK NIH HHS RC2 DK114777NIGMS NIH HHS R01 GM129380NIGMS NIH HHS RM1 GM139738NIH HHS R21 OD031973
6 · The paper itself

Abstract

Histone variants and the associated post-translational modifications that govern the stemness of haematopoietic stem cells (HSCs) and differentiation thereof into progenitors (HSPCs) have not been well defined. H3.3 is a replication-independent H3 histone variant in mammalian systems that is enriched at both H3K4me3- and H3K27me3-marked bivalent genes as well as H3K9me3-marked endogenous retroviral repeats. Here we show that H3.3, but not its chaperone Hira, prevents premature HSC exhaustion and differentiation into granulocyte-macrophage progenitors. H3.3-null HSPCs display reduced expression of stemness and lineage-specific genes with a predominant gain of H3K27me3 marks at their promoter regions. Concomitantly, loss of H3.3 leads to a reduction of H3K9me3 marks at endogenous retroviral repeats, opening up binding sites for the interferon regulatory factor family of transcription factors, allowing the survival of rare, persisting H3.3-null HSCs. We propose a model whereby H3.3 maintains adult HSC stemness by safeguarding the delicate interplay between H3K27me3 and H3K9me3 marks, enforcing chromatin adaptability.

Indexed as

AnimalsCD8-Positive T-LymphocytesCell Cycle ProteinsCell LineChromatinGranulocytesHematopoiesisHematopoietic Stem CellsHistone ChaperonesHistonesHumansHuman Umbilical Vein Endothelial CellsMacrophagesMethylationMiceMice, Inbred C57BLCell Cycle ProteinsChromatinHira protein, mouseHistone Chaperoneshistone H3 trimethyl Lys4HistonesTranscription Factors

Identifiers

PMID34961794
PMCPMC9166935
OpenAlexW4200242705

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.